Coave Therapeutics develops innovative gene therapy products for rare ophthalmic diseases to preserve visual autonomy in affected patients.

Biotechnology

Coave Therapeutics

Coave Therapeutics' headquarters in Paris, France

Rodolphe Clerval

Alexandre Simon

Romain Pettenaro

Lolita Petit

Claudia Mitchell

Julien Berger

Patricia Françon

Cédric Cousteix

Benedikt Timmerman

Frederic Chereau

Guillaume Blavier

Andrea Ballabio

Erwan Bézard

Bruno Montanari

Olivier Danos

Philippe Monteyne

Mark Kay

Alain Wagner

Robert Kotin

Aravind Asokan

Juliette Hordeaux

Anne Des Rieux

Thierry Laugel

The Scientific Advisors and Researchers team at Coave Therapeutics plays a pivotal role in advancing the development of gene therapy products for rare ophthalmic diseases. Comprised of experts in various scientific disciplines, the team is responsible for guiding research strategies, conducting preclinical studies, and ensuring that innovative therapies effectively target and treat underlying conditions. Their collaborative efforts are crucial for translating scientific discoveries into viable clinical applications that preserve visual autonomy for patients.

Scientific Advisors and Researchers

The Legal and Corporate Governance team at Coave Therapeutics is responsible for overseeing and ensuring compliance with regulatory requirements, corporate governance practices, and legal frameworks that support the development of gene therapies. This team collaborates closely with executives and directors to safeguard the company's interests and promote ethical business practices while navigating the complex landscape of biotechnology regulations.

Legal and Corporate Governance

This department focuses on the development and implementation of analytical projects and methodologies.

Analytical Development

This department oversees governance and strategic direction through board advisory roles.

Board Oversight

The Leadership Team at Coave Therapeutics is responsible for setting the strategic direction and operational oversight of the company. Comprising key executives such as the CEO, COO, and Chief Development Officer, the team collaborates to drive innovation in gene therapy, ensure legal and regulatory compliance, and ultimately enhance patient outcomes for rare ophthalmic diseases. Their collective expertise guides the company's mission to preserve visual autonomy for affected individuals.

Leadership Team

This department focuses on the research and development of biotechnological solutions and processes.

Coave Therapeutics

Org chart

Board & advisors

Teams

Scientific Advisors and Researchers

Legal and Corporate Governance

Analytical Development

Board Oversight

Leadership Team

Biotechnology Development

Offices

Coave Therapeutics

Org chart

Board & advisors

Teams

Scientific Advisors and Researchers

Legal and Corporate Governance

Analytical Development

Board Oversight

Leadership Team

Biotechnology Development

Offices

Related companies